Duopharma to supply 6.4 million doses of Sputnix V vaccine 


KUALA LUMPUR: Duopharma Biotech Bhd has entered into a deal to supply the Ministry of Health with 6.4 million doses of Covid-19 vaccine developed by Russia.

The supply is subject to the “Sputnik V” vaccine being approved by Drug Control Authority, Malaysia through technical evaluation by the National Pharmaceutical Regulatory Agency.

5.5 PAYDAY OFFER: 35% OFF Digital Access

Monthly Plan

RM 13.90/month

RM 9.04/month

Billed as RM 9.04 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Duopharma Biotech , vaccine , Sputnix V

Next In Business News

Censuria taps Affin to advance family office plan
How Asia-Pacific is fighting a fuel shock that could get worse
Local equity market remains resilient, reflects investor confidence, says Akmal Nasrullah
Tropicana to acquire Langkawi land for RM195.9mil
Khazanah launches Malaysia’s first tokenised sukuk in RM100mil pilot with SC
7-Eleven unit to acquire Seri Kembangan land for RM19mil
Ringgit closes higher against major, regional currencies
Eco-Shop banks on new outlets for profit growth
Alpha IVF to boost growth with new centres
Bank Islam issues 10th tranche of RM1bil Sukuk Murabahah

Others Also Read